Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Although, in Western countries, oxaliplatin-based regimens have been established as a gold standard treatment for patients with stage III or high risk stage II colon cancer after curative resection, in Japan fluorouracil-based regime...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yoshimura Kenichi, Uehara Keisuke, Tojima Yuichiro, Kawai Satoru, Mokuno Yasuji, Maeda Atsuyuki, Kyokane Takanori, Kobayashi Satoshi, Yoshioka Yuichiro, Nagino Masato
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2013-01-01
Saila:Trials
Gaiak:
Colon cancer
Stage III
Adjuvant chemotherapy
S-1
Sarrera elektronikoa:http://www.trialsjournal.com/content/14/1/17
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak